$HIMS

Update: FTC Suing Hims & Hers for Allegedly Sharing User Data With Meta, Snap

(Updates with Hims' official statement in the third paragraph.)Hims & Hers Health (HIMS) is being sued by the US Federal Trade Commission, the State of California, and the Utah Division of Consumer Protection, for allegedly sharing users' data with Meta Platforms (META), Snap (SNAP) and other online advertising companies, court documents show.The suit, filed in the US District Court for the Northern District of California, also alleges Hims charged consumers unwanted prescription medication subscriptions without their consent, and enrolls consumers in subscription plans "almost immediately after receiving consumers' medical intake forms.""This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims," Hims said on X. "This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense. We are confident in our position and will vigorously defend ourselves against these baseless claims."Hims & Hers shares were down over 11% in Wednesday trading.Price: $25.68, Change: $-3.65, Percent Change: -12.43%

Update: FTC Suing Hims & Hers for Allegedly Sharing User Data With Meta, Snap

(Updated with information from court documents in the first two paragraphs.)Hims & Hers Health (HIMS) is being sued by the US Federal Trade Commission, the State of California, and the Utah Division of Consumer Protection, for allegedly sharing users' data with Meta Platforms (META), Snap (SNAP) and other online advertising companies, court documents show.The suit, filed in the US District Court for the Northern District of California, also alleges Hims charged consumers unwanted prescription medication subscriptions without their consent, and enrolls consumers in subscription plans "almost immediately after receiving consumers' medical intake forms."Hims & Hers Health didn't immediately reply to a request for comment from.Hims & Hers shares were down over 11% in Wednesday trading.Price: $25.85, Change: $-3.47, Percent Change: -11.83%

Sectors1d ago

Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading

Healthcare stocks were slightly lower Wednesday afternoon, with the NYSE Healthcare Index down 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) fractionally lower.The iShares Biotechnology ETF (IBB) fell 0.7%.In corporate news, Hims & Hers Health (HIMS) is being sued by the US Federal Trade Commission for allegedly sharing users' data with Meta (META), Snap (SNAP) and other companies, Reuters reported. Hims & Hers Health shares dropped 11%.UnitedHealth (UNH) may lose significant funding as the Trump administration plans to terminate a Medicare prescription drug subsidy program, The Wall Street Journal reported. The government will end the $3.6 billion subsidy after 2026, which would have directed more than half of its funds to UnitedHealth next year, the report quoted the administration officials as saying. UnitedHealth shares were down 1.4%.Boston Scientific (BSX) lowered its full-year guidance below Wall Street's estimates on Wednesday, citing factors including weak demand for its Watchman heart implant. Its shares were up 0.8%.

$BSX$HIMS$UNH

Market Chatter: FTC Suing Hims & Hers Health for Allegedly Sharing User Data With Meta, Snap

Hims & Hers Health (HIMS) is being sued by the US Federal Trade Commission for allegedly sharing users' data with Meta Platforms (META), Snap (SNAP) and other online advertising companies, Reuters reported Wednesday, citing an FTC spokesperson.Hims & Hers Health didn't immediately reply to a request for comment from.Hims & Hers Health shares were down by more than 12% in Wednesday trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $25.09, Change: $-4.23, Percent Change: -14.43%

FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports

Street Color: Hims & Hers Health Facing US FTC's Lawsuit Over Alleged Data Sharing, Reuters Says

Sectors29d ago

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.3%.The iShares Biotechnology ETF (IBB) eased 0.2%.In corporate news, short seller Culper Research said Wednesday it has taken a short position in Tarsus Pharmaceuticals (TARS), alleging the commercialization of Xdemvy relies on a Medicare copay assistance structure that "raises serious Anti-Kickback Statute concerns." Tarsus shares were down 3.6%.Can-Fite BioPharma (CANF) shares surged 56% after it said its phase 2a trial of Namodenoson in advanced pancreatic cancer met its primary safety endpoint and showed durable survival in a subset of heavily pretreated patients.Hims & Hers Health (HIMS) shares jumped past 8% after BofA Securities raised its price target to $36 from $25, while keeping its neutral rating.BridgeBio Pharma (BBIO) has raised up to $1 billion in convertible preferred equity led by Sixth Street, with participation from HealthCare Royalty, a KKR (KKR) business, to fund upcoming product launches and pipeline development. BridgeBio shares were up 0.3%.

$BBIO$CANF$HIMS$TARS

Sectors29d ago

Sector Update: Healthcare Stocks Advance in Afternoon Trading

Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.3%.The iShares Biotechnology ETF (IBB) was 0.1% lower.In corporate news, Hims & Hers Health (HIMS) shares jumped nearly 9% after BofA Securities lifted the company's price target to $36 from $25, while keeping its neutral rating.Can-Fite BioPharma (CANF) shares surged 44% after it said its phase 2a trial of Namodenoson in advanced pancreatic cancer met its primary safety endpoint and showed durable survival in a subset of heavily pretreated patients.BridgeBio Pharma (BBIO) has raised up to $1 billion in convertible preferred equity led by Sixth Street, with participation from HealthCare Royalty a KKR (KKR) business, to fund upcoming product launches and pipeline development. BridgeBio shares were down 0.6%.

$BBIO$CANF$HIMS

Sectors29d ago

Sector Update: Healthcare

Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.4%.The iShares Biotechnology ETF (IBB) was fractionally higher.In corporate news, Hims & Hers Health (HIMS) shares jumped past 8% after BofA Securities lifted the company's price target to $36 from $25, while keeping its neutral rating.

Wire29d ago

BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating

Hims & Hers Health (HIMS) has an average rating of Hold and mean price target of $29.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $37.35, Change: $+2.68, Percent Change: +7.73%

Dow JonesNasdaq CompositeS&P 500$AMZN$BETH$BITO$BWLP$EEM$EETH$EXI$FAS$FAZ$GLD$GNRC$HIMS$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NVDA$PMR$QQQ$RTH$SLV$SOXX$SPY$TIGR$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD

Sectors58d ago

Sector Update: Healthcare Stocks Down Premarket Tuesday

Healthcare stocks were lower premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) easing 0.3%.Hims & Hers Health (HIMS) stock was up more than 2% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.Heron Therapeutics (HRTX) shares were down 18% after the company said the US District Court for the District of Delaware has ruled that claims in two of its Cinvanti injectable emulsion patents are invalid.Telix Pharmaceuticals (TLX) and United Imaging Healthcare North America signed a memorandum of understanding for a research collaboration in the US focused on integrated theranostics solutions. Telix Pharmaceuticals stock was down more than 2% pre-bell.

$HIMS$HRTX$IBB$TLX$XLV

Commodities58d ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Traders Assess AI Momentum

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively traded Invesco QQQ Trust (QQQ) retreated by 0.1% in Tuesday's premarket activity, as investors assessed whether recent AI-driven gains can be sustained.US stock futures were also lower, with S&P 500 Index futures down 0.2%, Dow Jones Industrial Average futures slipping 0.5%, and Nasdaq futures losing 0.1% before the start of regular trading.The Job Openings and Labor Turnover Survey, or JOLTS, for April will be released at 10:00 am ET.In premarket action, bitcoin was down by 2.9%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 2.9% lower, Ether ETF (EETH) retreated by 1.2%, and Bitcoin & Ether Market Cap Weight ETF (BETH) fell by 3%.Power Play:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) was flat, while the Vanguard Industrials Index Fund (VIS) was down 0.1% and the iShares US Industrials ETF (IYJ) was inactive.Generac (GNRC) stock was up more than 9% before the opening bell after the company signed a global supply agreement with an unnamed hyperscale data center operator to supply backup power generators.Winners and Losers:FinancialThe State Street Financial Select Sector SPDR ETF (XLF) was little changed. Direxion Daily Financial Bull 3X Shares (FAS) was down 0.4%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.7% higher.UP Fintech (TIGR) shares were down more than 2% pre-bell after the company swung to a Q1 non-GAAP net loss.EnergyThe iShares US Energy ETF (IYE) was down 2%, while the State Street Energy Select Sector SPDR ETF (XLE) was 0.3% lower.BW LPG (BWLP) stock was up 0.7% before market open after the company reported higher Q1 earnings.HealthcareThe State Street Health Care Select Sector SPDR ETF (XLV), Vanguard Health Care Index Fund (VHT) and iShares US Healthcare ETF (IYH) were little changed. The iShares Biotechnology ETF (IBB) was inactive.Hims & Hers Health (HIMS) stock was up 3% premarket after the company said it had completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) gained slightly, and the iShares US Technology ETF (IYW) was marginally down, while the iShares Expanded Tech Sector ETF (IGM) was up 0.4%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) increased 3%, while the iShares Semiconductor ETF (SOXX) rose by 2.5%.Nvidia (NVDA) shares were up more than 1% in premarket activity after Reuters reported, citing CEO Jensen Huang at the Computex event in Taipei, that the company has enough supply to support strong growth in its central processing units and graphics processing units.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.2%, and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was 0.4% lower. The iShares US Consumer Staples ETF (IYK) was flat. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) lost 0.5%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.5% higher.Amazon.com (AMZN) shares were down more than 1% pre-bell, extending a 3.5% fall at Monday's close. The company said Tuesday its Prime Day shopping event will take place from June 23 through June 26.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 0.8% to $91.41 per barrel on the New York Mercantile Exchange. Natural gas was down 1.8% to $3.12 per 1 million British Thermal Units. The United States Oil Fund (USO) was down by 1.1%, and the United States Natural Gas Fund (UNG) was 2% lower.Gold futures for July retreated by 1.2% to $4,558.30 an ounce on the Comex. Silver futures rose by 2% to $76.73 an ounce. SPDR Gold Shares (GLD) was up by 1%, and the iShares Silver Trust (SLV) increased by 1.9%.

Sectors58d ago

Sector Update: Healthcare

Healthcare stocks were steady premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) inactive.Hims & Hers Health (HIMS) stock was up more than 3% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.

Sectors70d ago

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding about 0.7%.The iShares Biotechnology ETF (IBB) was up 0.8%.In corporate news, West Pharmaceutical Services (WST) shares rose 3.1% after the company said it has restored its core enterprise systems following a recent cybersecurity attack.Eli Lilly (LLY) shares added 2.6% after the company said its investigational retatrutide delivered "clinically meaningful" weight loss in a phase 3 trial, where all doses met the primary and key secondary endpoints at 80 weeks.Hims & Hers Health (HIMS) said Thursday that it has launched generic semaglutide for eligible customers in Canada. Its shares gained 2.7%.Moderna's (MRNA) experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory panel on June 18, Bloomberg reported. Moderna shares were down 1.5%.

$HIMS$LLY$MRNA$WST

Sectors70d ago

Sector Update: Healthcare Stocks Rise Thursday Afternoon

Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.5%.The iShares Biotechnology ETF (IBB) was up 0.6%.In corporate news, Eli Lilly (LLY) shares rose 2.1% after the company said its investigational retatrutide delivered "clinically meaningful" weight loss in a phase 3 trial, where all doses met the primary and key secondary endpoints at 80 weeks.Hims & Hers Health (HIMS) said Thursday that it has launched generic semaglutide for eligible customers in Canada. Its shares popped 3.3%.Moderna's (MRNA) experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory panel on June 18, Bloomberg reported. Moderna shares were down 1.5%.

$HIMS$LLY$MRNA

Wire70d ago

Hims & Hers Launches Generic Semaglutide in Canada

Hims & Hers Health (HIMS) said Thursday that it has launched generic semaglutide for eligible customers in Canada.Canadian customers can access personalized treatment plans starting at 149 Canadian dollars ($108) per month, the company said.Care plans may include GLP-1 options alongside ongoing support and guidance on nutrition, movement and sleep, the company said.Price: $22.80, Change: $-0.22, Percent Change: -0.96%

Dow JonesNasdaq CompositeS&P 500$DELL$HIMS$NVO$SE$VG

Asia Markets79d ago

US Equity Futures Lower Pre-Bell as Trump Says Middle East Ceasefire on 'Life Support'

US equity futures were lower pre-bell Tuesday as the standoff continued in the Middle East, with the ceasefire between the US and Iran on shakier ground after President Donald Trump said it was "on life support."Dow Jones Industrial Average futures were 0.1% lower, S&P 500 futures were down 0.4%, and Nasdaq futures were 0.8% lower.Trump told reporters in the White House that the month-old truce is "unbelievably weak." He had rejected Iran's response to the US peace proposal. Iran's most recent counteroffer had included a demand for war reparations, an end to sanctions, full sovereignty over the Strait of Hormuz, and the release of frozen Iranian assets.Traders monitored the latest round of earnings, with Sea (SE) and Venture Global (VG) posting higher Q1 earnings and revenue.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 3.2% at $107.57 per barrel and US West Texas Intermediate crude 3.1% higher at $101.08 per barrel.The April consumer price index, released at 8:30 am ET, gained 0.6% as expected, compared with a 0.9% increase in the previous month, according to estimates compiled by Bloomberg.Federal Reserve Chicago President Austan Goolsbee is slated to speak Tuesday.In other world markets, Japan's Nikkei closed 0.5% higher, Hong Kong's Hang Seng ended 0.2% lower, and China's Shanghai Composite finished 0.3% lower. Meanwhile, the UK's FTSE 100 was down 0.4%, and Germany's DAX index was 1.1% lower in Europe's early afternoon session.In equities, Novo Nordisk (NVO) stock was up 2.5% after the company said a higher dose of its Wegovy drug helped people with obesity lose "significant amounts" of weight irrespective of how quickly their body responds to the treatment, based on a new sub-analysis from a clinical trial. Sea and Venture Global shares were up 11% and 9.4%, respectively, after the companies reported their Q1 financial results.On the losing side, Dell Technologies (DELL) shares were down 2.1% after UBS downgraded the stock to neutral from buy. Hims & Hers Health (HIMS) stock was down 15% after the company reported a swing to Q1 loss.

US Markets80d ago

Stocks Down Pre-Bell as US Rejects Iran's Response to Peace Plan; Investors Await Key Inflation Data

The benchmark US stock measures were pointing lower before the opening bell Monday as the US rejected Iran's response to its proposal to end their war in the Middle East, while traders await key inflation data later in the week.The S&P 500 and the Nasdaq edged down 0.1% each in premarket activity, while the Dow Jones Industrial Average was slightly in the red. The indexes finished Friday trading in the green, with the S&P 500 and the Nasdaq logging new closing highs.Iran formally sent a response to the latest US peace proposal, outlining its own demands and leaving key gaps between the two sides, The Wall Street Journal reported Sunday. Tehran's response didn't resolve Washington's demand for commitments on its nuclear program and stockpile of highly enriched uranium, according to the report."I have just read the response from Iran's so-called 'representatives,'" President Donald Trump said in a social media post on Sunday. "I don't like it - totally unacceptable!"Iran has reportedly insisted on compensation for war damages, control over the crucial Strait of Hormuz, lifting all sanctions on it and the release of frozen assets.Israeli Prime Minister Benjamin Netanyahu reportedly said in a recent interview with CBS that the war with Iran is not over. "There is still enrichment sites that have to be dismantled, there's still proxies that Iran supports, there are ballistic missiles that they still want to produce ... there's work to be done," Netanyahu said.West Texas Intermediate crude oil increased 2.5% to $97.79 a barrel before the open, while Brent advanced 2.4% to $103.72.Treasury yields were trending upwards in premarket action, with the two-year rate rising 2.9 basis points to 3.92% and the 10-year rate gaining 2.6 basis points to 4.39%.The consumer price index for April is scheduled to be released on Tuesday, followed by data on wholesale prices for the same month on Wednesday. Last month's retail sales report is due on Thursday.Last week, government data showed that the US economy added more jobs than expected in April, while the unemployment rate remained unchanged.For the Federal Reserve, the hiring momentum further shifts the focus to inflation, keeping it on the sidelines for now, "and raising the possibility of future rate hikes," Stifel Chief Economist Lindsey Piegza said in a report e-mailed toon Friday.Consumer sentiment continued to fall in May as cost pressures tied to the Middle East conflict sent the measure tumbling to fresh lows, a survey by the University of Michigan showed Friday.Monday's thin economic calendar has the existing home sales report for April at 10 am ET.Constellation Energy (CEG), Circle Internet (CRCL), Fox (FOX, FOXA), Mosaic (MOS) and Monday.com (MNDY) are slated to report their latest financial results before the bell, among others.Shares of Micron Technology (MU) rose 2.6% pre-bell after closing Friday's trading session up 16%. Hims & Hers Health (HIMS) added 4.5% after the stock closed 10% higher in the previous session. Intel (INTC) climbed 5.5%.Gold declined 1.3% to $4,671 per troy ounce, while bitcoin slipped 0.5% to $81,015.

Dow JonesNasdaq CompositeS&P 500$CEG$CRCL$FOX$FOXA$HIMS$INTC$MNDY$MOS$MU

Research97d ago

JPMorgan Initiates Coverage on Hims & Hers Health With Overweight Rating, $35 Price Target

Hims & Hers Health (HIMS) has an average rating of overweight and mean price target of $26.74, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)